EUVIMEDExplore EUVIMED
CrossrefInfo card

Controversies in renal anemia management

Onyekachi Ifudu

Dialysis & Transplantation · 2006

DOI: 10.1002/dat.20006 ↗
AbstractBibliographic details

Abstract

Abstract Anemia plays a key role in generating excess cardiovascular morbidity and mortality in patients with chronic kidney disease. Among patients with end‐stage renal disease, low hemoglobin levels contribute to an increased rate of hospitalization and shortened survival. Several issues in the pathogenesis and management of renal anemia, including the use of recombinant erythropoietin, are controversial and unresolved. In addition, the management of anemia has major economic implications. Clarifying these issues ultimately could enhance patient outcomes while lessening the need for erythropoietin and intravenous iron, which could potentially save millions of dollars.

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.

View plans →